To establish whether rSP could stimulate NK cell function and also to optimize the experimental conditions, we assessed the activation (CD25) and apoptosis (Annexin V) markers’ expression on NK cell-gated (CD3-CD56+) rSP-stimulated PBMCs from HD, enrolled irrespective of their previous infection and/or vaccination. This evidence concerns the gene ANXA5 and Huntington disease.